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Summary 
During T cell development in the thymus, the expression ofthymic shared antigen-1  (TSA-1)/ 
stem cell antigen-2 (Sca-2), a glycosylphosphatidylinositol (GPI)-anchored differentiation anti- 
gen, is developmentally regulated. The expression level of TSA-1 is the highest in most imma- 
ture CD4- CD8- thymocytes, high in CD4 + CD8 + thymocytes, but barely detectable in ma- 
ture  CD4+CD8 -  or CD4-  CD8 +  thymocytes and peripheral  T  cells.  We  have previously 
shown that surface TSA-1 expression in peripheral T  cells is induced upon activation and that 
anti-TSA-1 mAb inhibits the T  cell receptor (TCR) signaling pathway in activated T  cells. In 
the present study, we have analyzed a role of TSA-1 in thymic selection events, especially in 
TCP,-mediated  apoptosis.  In  in  vitro  experiments, anti-TSA-1  blocked anti-CD3-induced 
cell death ofT cell hybridomas. When anti-TSA-1 was injected into newborn mice in vivo to- 
gether with anti-CD3e  or anti-TCR-[3,  TCR/CD3-mediated  apoptosis of thymocytes was 
almost completely blocked. The blockade of apoptosis was defined by the inhibition of, first, 
the  decrease in  total number of thymocytes; second,  the  decrease in  percentages  of CD4  + 
CD8 § thymocytes; and third, the induction of  DNA fragmentation. However, anti-TSA-1 did 
not block either steroid- or radiation-induced apoptosis, indicating that a signal via TSA-1 does 
not inhibit a common pathway of thymocyte apoptosis. Since TCR-mediated apoptosis is piv- 
otal in thymic ontogeny, these results suggest that TSA-1/Sca-2 is an important cell surface 
molecule regulating the fate of a developing T  cell. 
M 
aturation  of T  cells  in  the  murine  thymus  can  be 
.monitored by changes  in  expression of several cell 
surface markers  (1).  Significant progress has been made in 
the developmental pathway of  immature thymocytes by classi- 
fying thymocytes into  subpopulations  on the basis  of the 
expressions of diverse differentiation Ags.  One differentia- 
tion Ag that is potentially important in T  cell development 
is thymic shared antigen-1  (TSA-1)  (2,  3).  TSA-1, which 
is identical to stem cell antigen-2  (Sca-2)  (4,  5), is a Ly- 
6-related protein expressed on early thymic precursor cells, 
immature  CD3 -/l~  thymocytes,  and  thymic  epithelial 
cells. The importance of this Ag as a marker in early T  cell 
development has been defined recently. Bone marrow stem 
cells that home to and populate the thymus are Sca-2 +, in- 
dicating that  Sca-2 is  a marker for bone marrow prothy- 
mocyte (6, 7). Although it is suggested that TSA-1 plays a 
regulatory role in thymocyte maturation  (3,  8),  the exact 
function of TSA-1/Sca-2 in T cell development remains to 
be elucidated. 
In previous studies, we have analyzed the expression and 
the function of TSA-1 in mature T  cells (9, 10). Although 
fleshly isolated T  cells  did not express TSA-1  on the  cell 
surface, stimulation of T  cells induced a marked increase of 
surface TSA-1 expression. These TSA-1 molecules on acti- 
vated T  cells have a negative regulatory role in the TCR- 
mediated activation pathway,  since  anti-TSA-1  inhibited 
anti-CD3-induced IL-2 production by T  cell hybridomas 
and normal activated T cells. However, the results obtained 
from these in vitro experiments do not define a physiologi- 
cal role of TSA-1 in vivo, nor do they identify a relevance 
of this function of TSA-1 to T  cell development. 
In  the  present  study,  we  investigated  whether  TSA-1 
plays a role in thymocyte differentiation by virtue of its abil- 
ity  for  downmodulating  TCR-mediated  signal  transduc- 
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is  able  to  inhibit  TCR-mediated  apoptosis  in  immature 
thymocytes. The data demonstrated that the TSA-1 inhibi- 
tory pathway is operative in blocking TCR-mediated apop- 
tosis in vivo. 
Materials and Methods 
Mice and Cell Lines.  Timed pregnant C57BL/6 mice were pur- 
chased from the Shizuoka Expertmental Animal Laboratory (Hama- 
matsu, Japan). DO. 11.10 is a murine T cell hybridoma (11). 
mAbs and Reagents.  The following Abs were used: 145-2Cll 
(12),  anti-CD3e;  H57-597  (13),  anti-TCIK-[3;  G7  (14),  anti- 
Thy-l.2; and P1KST1, anti-TSA-1  (9). These mAbs were puri- 
fied with either Protein A- or protein G-Sepharose (Pharmacia 
Biotech, Inc., Piscataway, NJ) from culture supernatants. Normal 
hamster IgG was purchased from Cappel (Durham, NC). Hydro- 
cortisone 21-acetate and propidium iodide were purchased from 
Sigma Chemical Co.  (St. Louis, MO).  For cell staining, FITC- 
conjugated  anti-CD8  and  phycoerythrin-conjugated anti-CD4 
were obtained from Becton Dickinson (Mountain View, CA). 
Irradiation.  Newborn mice were irradiated with 125, 250,  or 
500 cGy. Irradiation was done with a GammaCel140 equipped with 
a 137Cs source. 
Immunofluorescence Staining and FCM Analysis.  Cell staining pro- 
cedure and FCM anaJysis using FACScan (Becton Dickinson) were 
as described (9). 
Gel Analysis of DNA Fragmentation.  Thymocyte pellets (1  ￿  106) 
were resuspended in 20 gl oflysis buffer (10 mM EDTA, 50 mM 
Tris-HCl, pH 8.0,  containing 0.5% (w/v) sodium lauryl sarkosi- 
nate and 0.5 mg/ml RNase A) and incubated at 50~  for 1 h; 10 Ixl 
proteinase K (1.5  mg/ml) were added to each sample, and incu- 
bation at  50~  was  continued  for  another hour.  The  samples 
were then heated to 70~  and 10 ~1 of 10 mM EDTA contain- 
ing  1%  (w/v)  low melting agarose, 0.25%  (w/v)  bromophenol 
blue, and 40% (w/v) glycerol were mixed with each sample, and 
incubation was continued for 1 h. The samples were then loaded 
on a 2% (w/v) agarose gel containing I  I~g/ml ethidium bromide 
in Tris-borate buffer and visualized by UV fluorescence. 
Results 
Inhibition of Anti- TCR-Induced Apoptosis by Anti-TSA- 1 
mAb in T  Cell Hybridomas.  Our previous study demonstrated 
a  negative  regulatory  role  of TSA-1  in  the  TCR/CD3- 
mediated signaling pathway as assessed by the inhibition of 
IL-2 production from T  cell hybridomas (9). We also dem- 
onstrated that  PRST1,  an  anti-TSA-1  mAb,  exhibited an 
effect on  T  cells in the absence of accessory cells in some 
experiments, indicating that our mAh has the ability to de- 
liver a signal to T  cells directly (10).  Since T  cell hybrido- 
mas are known  to  undergo  apoptosis following activation 
(15), we tried to determine whether anti-TSA-1 is capable 
of inhibiting the anti-CD3-induced death pathway in T  cell 
hybridomas. As shown  in  Fig.  1,  when  T  cell hybridoma 
DO.11.10.  cells  were  stimulated  with  anti-CD3  in  the 
presence of irradiated Thy-l~depleted spleen cells, DO. 11.10. 
cells  underwent  ceil  death  as  expected.  However,  anti- 
CD3-induced cell death was clearly inhibited by the addi- 
tion  of PRST1.  This  effect was  specific for  PRST1,  be- 
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Figure  1.  Inhibition  of anti-CD3-induced  apoptosis by anti-TSA-1 
mAb in T cell hybridomas. T cell hybridoma DO.11.10  cells (5  X  105 
cells per well) and 3,000-tad-irradiated Thy-l-depleted spleen cells (1 x 
106 cells per well) were cultured for 12 h with the indicated Abs. The Abs 
used were 2C11 (anti-CD3~ mAb, 50 ng/nfl); NHIgG (normal hamster 
IgG, 10 btg/ml); PRST1 (anti-TSA-1 mAb,  10 p,g/ml); and G7 (anti- 
Thy-1 mAb, 10 p~g/ml). Cell death ofT cell  hybridomas was determined 
by propidium iodide (10 ~g/ml) staining for nonpermeabihzed cells. The 
discrimination between DO. 11.10 cells and spleen cells was performed by 
electrical gating using forward versus side scatter dot plot. The region 
shown with horizontal solid line in each histogram represents the staining 
of dead cells and the percentage of such cells indicated. 
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failed  to  exhibit  inhibitory  effects  on  anti-CD3-induced 
cell death  of T  cell hybridomas  (Fig.  1).  Thus,  ligation  of 
TSA-1  by  PRST1  can  protect  T  cell  hybridomas  from 
anti-TCR-induced  apoptosis in vitro. 
Inhibition of Anti-TCR-Induced Apoptosis by Anti-TSA- 1 
mAb in Neonatal Thymocytes In Vivo.  We next asked whether 
TSA-1 plays a role in thymocyte development by its ability 
to  downmodulate  TCR/CD3-mediated  signal  transduc- 
tion.  Since  one  outcome  of TCR  signaling  in  early  thy- 
mocytes  is  clonal  deletion  by  programmed  cell death,  we 
examined whether anti-TSA-I  is capable of inhibiting thy- 
mocyte  apoptosis  induced  by  anti-CD3  injection in  vivo. 
In preliminary  experiments,  we  analyzed  doses  of PRST1 
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Figure 2.  Rescue from anti-TCR-induced apoptosis with anti-TSA-1 mAb in neonatal thymocytes in vivo. (A and B) Newborn C57BL/6 mice at day 
0 (within 24 h of birth) were injected intraperitoneally  with 100 lug of PRST1 or normal hamster IgG (NHIgG). After 12 h, mice were injected again 
with 100 lug of PRST1 or NHIgG together with either 2C11  (anti-CD3e;  A) or H57-597 (anti-TCR-I~; B) at the dose indicated. 20 h after the injection 
ofanti-TCR antibodies, thymuses were removed from the mice and viable cells were counted.  Results are presented  as mean •  SE of 4-7 independent 
experiments.  (C) Newborn mice were injected  with 100 lug of PRST1 or NHIgG. After 12 h, mice were injected again with 100 lug of PRST1 or 
NHIgG together  with 2Cll as described above. Thymocytes from these mice were stained wath FITC-conjugated anti-CD8 and PE-conjugated  anti- 
CD4 and were analyzed with FCM. 
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used  (total  200  btg per  mouse  administered  with  100  ixg 
per injection  at day 0  and  day 1  of birth)  was determined 
by FCM analysis (data not shown). 
As reported previously (16), when 3 or 10 ~g of the pu- 
rified  anti-CD3e  was  injected  into  newborn  mice,  apop- 
totic cell death was induced in neonatal thymocytes at  16- 
20 h  after the injection,  resulting in the reduction of total 
thymocyte number (Fig. 2 A) and the decrease in the per- 
centage ofCD4  + CD8 + thymocytes (Fig. 2 C, panels c and e). 
However,  cell death of thymocytes induced by anti-CD3e 
was  dramatically  inhibited  when mice were  injected  with 
PRST1 along with anti-CD3~ (Fig. 2 A). The inhibition of 
thymocyte  apoptosis  by  PRST1  was  confirmed  by  FCM 
analysis,  such  that  the  percentages  of CD4  +  CD8 +  thy- 
mocytes from newborn mice injected with anti-CD3e plus 
PRST1 was not decreased in contrast with those from mice 
injected with  anti-CD3e  plus  normal hamster  IgG  (Fig.  2 
C, panels  d and f).  It should be noted that the injection of 
PRST1  alone  did  not  affect the  development  of neonatal 
thymocytes  (Fig.  2).  The  inhibitory  effect  of PRST1  was 
not limited to anti-CD3-induced cell death,  since PRST1 
was capable of inhibiting cell  death of thymocytes induced 
by anti-TCR-[3  injection  (Fig.  2  /3). To  confirm that  the 
death  of neonatal  thymocytes induced by anti-TCR  anti- 
body occurred by apoptosis, and to check that the apoptosis 
was in fact protected by PRST1,  chromosomal DNA was 
prepared from neonatal thymocytes from mice injected with 
anti-CD3e or anti-CD3~ plus PRST1  and was analyzed by 
agarose gel electrophoresis.  As shown in Fig. 3, at 20 h after 
the  injection with  10  btg of anti-CD3e,  most of the  thy- 
mic DNA was degraded in the stepladder fashion that is char- 
acteristic  of apoptosis.  In contrast, PRST1  injection clearly 
blocked the  anti-CD3-induced  fragmentation  of chromo- 
somal DNA.  As a  control, mice were injected  either with 
anti-CD3~  plus  normal  hamster  IgG  or  anti-CD3e  plus 
anti-Thy-1.  These treatments  did not inhibit  the degrada- 
tion  of chromosomal  DNA.  Thus,  these  results  demon- 
strate  that  engagement  of TSA-1  by PRST1  is  capable  of 
inhibiting  the  TCR  signaling  pathway  in  immature  thy- 
mocytes, resulting in protection from apoptosis in vivo. 
Effect of Anti-TSA-1  mAb on  Thymocyte Apoptosis Induced 
by Glucocorticoids or Irradiation.  Apoptosis ofthymocytes can 
be induced by various stimuli such as glucocorticoids or ir- 
radiation  (17).  We  next  examined  whether  apoptosis  in- 
duced by stimuli other than TCR  cross-linking can also be 
blocked by a  signal  through TSA-1.  Newborn  mice were 
injected  with  100  b~g of PRST1  at  day 0  and  day  1,  and 
the  injection  of hydrocortisone  or y-irradiation  was  per- 
formed immediately after the  second injection  of PRST1. 
As shown in Fig.  4  A, the injection  of hydrocortisone in- 
duced thymocyte apoptosis in a dose-dependent fashion. In 
Figure 3.  Agarose gel electrophoresis of DNA extracted from neonatal 
thymocytes of mice injected with anti-CD3e mAb and anti-TSA-1 mAb. 
Newborn mice were treated as described in Fig. 2. The genomic DNA 
was extracted and analyzed by gel electrophoresis. Molecular size stan- 
dards are shown at left. 
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Figure 4.  The effect ofanti-TSA-I 
mAb on steroid- or radiation-induced 
apoptosis  in  neonatal thymocytes. 
Newborn  C57BL/6  nfice at  day 0 
(within 24 h of birth) were injected 
intraperitoneally  with  100  ~g  of 
PRST1  or  normal hamster IgG 
(NHIgG). After 21  h  (A)  or  13  h 
(B), the  mice were injected again 
with 100 ~g of PRST1 or NHIgG. 
Mice were  then  injected with  hy- 
drocortisone (A) or irradiated (B) at 
different doses as indicated. After 8 h 
(A) or 12 h (B), thymuses were re- 
moved  from  these mice. The  ge- 
nomic DNA was extracted and ana- 
lyzed  by gel electrophoresis. Molecular 
size standards are shown at left, contrast with anti-CD3-induced  apoptosis, steroid-induced 
apoptosis was not blocked by PRST1  injection  at any dose 
of hydrocortisone.  Similarly, radiation-indued  apoptosis was 
resistant to a signal through  TSA-1  (Fig.  4  B).  Thus,  these 
results indicate that anti-TSA-1  does not inhibit a common 
pathway  of thymocyte  apoptosis,  but  specifically  blocks 
TCR-mediated  apoptosis. 
Discussion 
In a previous study, we described a mAb against TSA-1 
that is capable of inhibiting anti-TCR/CD3-mediated  T  cell 
activation in T  cell hybridomas  (9).  The further functional 
characterization  of TSA-1  revealed that TSA-1  delivers an 
inhibitory  signal  to  normal  activated  T  cells,  and  that  the 
signal  through  TSA-1  blocks  an  early  signaling  event  in 
TCR/CD3-mediated  T  cell activation  (10).  The fact that 
thymocytes  dramatically  downregulate  TSA-1  surface  ex- 
pression while maturing from CD4 + CD8 + thymocytes to 
CD4 + CD8-  or CD4-  CD8 + mature thymocytes led us to 
explore  the  possibility that this  molecule  could participate 
in thymic selection events by virtue of its ability for modu- 
lating  TCR  signaling.  Since  negative  selection  of thymo- 
cytes is generally considered  to be caused by TCR-medi- 
ated  apoptosis  (18),  we  investigated  in  the  present  study 
whether  a  signal via TSA-1  is able  to  block apoptosis  in- 
duced by cross-linking of the TCR.  The data clearly dem- 
onstrated  the  ability of TSA-I  to deliver a  signal  to block 
anti-TCR-mediated  apoptosis of immature thymocytes. 
It is interesting to note that anti-TSA-1  injection in vivo 
did not affect positive selection in neonatal thymocytes (see 
Fig.  2  C).  We  did  not  observe  the  reduction  of mature 
CD4 + CD8-  or CD4-  CD8 + thymocytes in mice contin- 
uously injected with PRST1  twice a week from birth (data 
not shown).  It is thus  far unknown  why anti-TSA-1  does 
not  inhibit  TCR-mediated  positive  selection  in  contrast 
with the inhibitory effect on TCR-mediated apoptosis. The 
difference between stimulation with MHC plus peptides and 
that with  anti-TCR  may account  for the  failure  to  detect 
an effect on positive selection.  Alternatively,  since the low 
affinity interaction between the TCR  and its ligand is con- 
sidered to be capable of inducing positive selection, a signal 
via TSA-1 may not block TCR  signaling generated through 
such low affinity interaction. 
Ly-6A/E has been recently shown,  in experiments with 
transgenic  mice,  to  mediate  cell-cell  adhesion  (19).  The 
Ly-6-related proteins may have a role in thymocyte devel- 
opment,  since  the  maturation  of thymocytes  was severely 
affected  in  the  transgenic  mice  overexpressing  Ly-6A.2 
(20).  If Ly6-A.2  expressed  on  transgenic  thymocytes  has 
the same inhibitory effect on TCR  signaling as TSA-1, the 
maturational  arrest  observed  in  transgenic  mice  could  be 
explained by this function.  In support of this, mAbs against 
Ly-6 proteins have been shown to exhibit an inhibitory ef- 
fect on the TCR  signaling pathway in mature T  cells (21). 
There exist several mAbs against TSA-1/Sca-2.  Although 
we  have not  tested  whether  other  anti-TSA-1/Sca-2  Abs 
are capable of inhibiting  TCR-mediated  apoptosis of thy- 
mocytes, our previous work using T  cell hybridomas clearly 
demonstrated that our mAb, PRST1,  is the only mAb that 
has the ability to induce  downmodulation  of TCR  signal- 
ing  (10).  PRST1  could  be  different  from  other  mAbs  in 
that it recognizes a functional epitope within a TSA-1 mol- 
ecule,  as  has  been  reported  in  other  GPI-anchored  pro- 
teins.  Taking  advantage  of the  property  of our mAb,  we 
investigated  a  potential  role  of TSA-1  in  T  cell  develop- 
ment in vivo in this study.  However, the determination  of 
physiological significance of our findings may await identi- 
fication of the  natural ligand  of TSA-1  in thymus.  Studies 
are now in progress to investigate the ligand for TSA-1  us- 
ing TSA-l-human  IgG proteins as the probe. 
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